A growing number of businesses are struggling to find smaller warehouse spaces, even though the pandemic-era uptick in warehouse demand has cooled. According to real-estate services firm Cushman & Wakefield, the vacancy rate for U.S. warehouses under 100,000 square feet was 3.9% in the fourth quarter, much lower than the 6.7% overall vacancy rate. This
As the UK’s only registered charity dedicated to supporting voluntary operated emergency response, Arrive Alive plays a vital role in funding lifesaving vehicles and equipment for Community First Responders (CFRs). These medically trained volunteers are dispatched to life-threatening 999 calls and can reach emergencies in crucial seconds or minutes, utilising their proximity to the community
The Supreme Court ruled on March 3 that even if a company has servers abroad, it can still be held liable for services violating patents concerning online video distribution that were obtained in Japan. Presiding Judge Koichi Kusano of the court’s Second Petty Bench issued its first-ever ruling on the matter, saying, “If an infringing activity is
Ultra Short Term Mutual Funds are an ideal option for investors seeking low-risk, short-term investments. These ultra short-term funds offer liquidity, stability and better returns than savings accounts. Designed for investors who want to park their money for a short duration, ultra-short-term funds offer a low-risk option with relatively brief lending durations. Index Fund Corner
KOASTAL-2 and -3 studies optimized based on learnings from KOASTAL-1; topline data expected from KOASTAL-3 in the first quarter of 2026 and -2 in the second quarter of 2026 Topline data from NMRA-511 in Alzheimer’s disease agitation expected by the end of 2025 Expect to progress next M4 positive allosteric modulator (PAM) program into the
– Phase 3 registrational trials evaluating petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC and petosemtamab monotherapy in 2/3L r/m HNSCC enrolling; expected to be substantially enrolled by YE25 – Petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC phase 2 trial ongoing with clinical data update planned for 1H25 – Petosemtamab
Planning Activities Are Ongoing for Next Phase of Cemsidomide Clinical Development in Multiple Myeloma and Non-Hodgkin’s Lymphoma; Trials Expected to Initiate in Early 2026 CFT1946 Phase 1/2 Trial Continues to Progress Across Multiple Cohorts; Data in Melanoma and Colorectal Cancer Expected in Second Half of 2025 Cash, Cash Equivalents and Marketable Securities of $267.3 million
(Bloomberg) — A diversified investment strategy that seeks to juice returns through leverage is finding new love among big money managers — more than a decade after it blew up during the 2008 financial crisis. The approach, widely known as “portable alpha,” uses derivatives to track returns of long-only indexes and then invests the
Targeting NDA submission for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025 through accelerated approval pathway; on track to initiate APOLLO post-marketing confirmatory trial by mid-2025 Positive update from Phase 1b trial of DISC-0974 in patients with anemia of myelofibrosis (MF) presented at ASH 2024; initial data from ongoing Phase 2 expected in H2 2025
Share Tweet Share Share Email Supply chain management is a dynamic and demanding responsibility that presents continuous challenges for businesses. Any hold-ups can have a significant impact on the entire business, causing stock outages, missed sale opportunities, or delays in customers receiving the orders. There are various tools